StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO.NS
Sector
Location
Market Cap
USD 6.63 B
Share Price
USD 38.71
Avg Daily Volume
216,790
Change (1 day)
0.64%
Change (1 year)
24.18%
Change (YTD)
47.16%
GlaxoSmithKline Pharmaceuticals Limited Total Assets for the year ending March 31, 2025: USD 480.73 M
GlaxoSmithKline Pharmaceuticals Limited Total Assets is USD 480.73 M for the year ending March 31, 2025, a 12.74% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
GlaxoSmithKline Pharmaceuticals Limited Total Assets for the year ending March 31, 2024 was USD 426.40 M, a 5.35% change year over year.
-
GlaxoSmithKline Pharmaceuticals Limited Total Assets for the year ending March 31, 2023 was USD 404.74 M, a -33.67% change year over year.
-
GlaxoSmithKline Pharmaceuticals Limited Total Assets for the year ending March 31, 2022 was USD 610.20 M, a 43.51% change year over year.
-
GlaxoSmithKline Pharmaceuticals Limited Total Assets for the year ending March 31, 2021 was USD 425.19 M, a 2.19% change year over year.
Competitors
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Cencora, Inc.
USD 291.17
COR
-4.16
-1.41%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.29
600276.SS
-0.03
-0.39%
Takeda Pharmaceutical Company Limited
USD 30.65
4502.T
-0.23
-0.74%
Haleon plc
USD 5.08
HLN.L
-0.08
-1.63%
Daiichi Sankyo Company, Limited
USD 22.61
4568.T
-0.33
-1.46%
UCB SA
USD 196.68
UCB.BR
-0.30
-0.15%
Hansoh Pharmaceutical Group Company Limited
USD 3.92
3692.HK
+0.07
1.85%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
GSK plc
USD 19.21
GSK.L
-0.20
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.74
REGN
+12.83
2.40%
Cencora, Inc.
USD 291.17
COR
-4.16
-1.41%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.29
600276.SS
-0.03
-0.39%
Takeda Pharmaceutical Company Limited
USD 30.65
4502.T
-0.23
-0.74%
Haleon plc
USD 5.08
HLN.L
-0.08
-1.63%
Daiichi Sankyo Company, Limited
USD 22.61
4568.T
-0.33
-1.46%
UCB SA
USD 196.68
UCB.BR
-0.30
-0.15%
Hansoh Pharmaceutical Group Company Limited
USD 3.92
3692.HK
+0.07
1.85%